Fatigue, physical fitness and quality of life in patients with Hepatitis C virus infection during the combination therapy
View File(s)
- Author(s)
- Details
-
Shiow-Ching Shun, RN; Chen-Hua Liu, MD
- Sigma Affiliation
- Gamma Rho
Visitor Statistics
Visits vs Downloads
Visitors - World Map
Top Visiting Countries
Country | Visits |
---|
Top Visiting Cities
City | Visits |
---|
Visits (last 6 months)
Downloads (last 6 months)
Popular Works for Shun, Shiow-Ching by View
Title | Page Views |
---|
Popular Works for Shun, Shiow-Ching by Download
Title | Downloads |
---|
View Citations
Citations
Session presented on Tuesday, November 10, 2015:
Introduction: An increasing incidence of liver cancer mainly attributed to Hepatitis C Virus (HCV) infection has been observed in Taiwan over the last 20 years. The current mainstay of treatment for patients with chronic HCV infection is the combination therapy of peglated interferon (peginterferon) plus ribavirin. Most patients experience multiple symptoms along with the therapy and fatigue is the most distressed symptoms with decreasing physical function that might affect their quality of life. However, there is no study to examine the changes of fatigue, physical fitness, and their relations with quality of life during the treatment.
Objective: The aims of the study were to (1) examine the changes of physical fitness component (e.g., muscular strength and cardiopulmonary fitness), fatigue, and quality of life, and (2) explore the significant factors related to QOLover the 24 weeks of combined treatment.
Methods: A prospective correlational and longitudinal design was used. Patients with chronic hepatitis C infection who are scheduled to receive the combined therapy were recruited from a medical center at outpatient settings in Northern Taiwan. Data were collected from patients through interviews using a set of structured questionnaires and measuring physical fitness by using 6-minute walk test, hand dynamometer, and hand-held dynamometer at four time points: baseline (before treatment, T0), and at 8 weeks (T1), 16 weeks (T2), and 24 weeks (T3) during treatment. Descriptive statistics and generalized estimating equations analysis were used to explore the changes of the measured variables.
Results: A total of 139, 134, 131 and 122 patients have completed the procedures at T0, T1, T2, and T3, respectively. The majority of HCV gene type was type I (49.7%). Fatigue was the most distressed symptoms and its intensity reached the peak at T1 and decreased folowing the treatment and significant decreased in mental related quality of life. All the measures of physical fitness decreased during treatment but only hand grip and 6-minutes walking distance (6-MWD) were significantly decrease. The 6-MWD was positively related to change of physical related QOL. Lower level of the hip muscle strength was related to change of mental related QOL.
Conclusions: Decreasing the 6-MWD and the hip muscle strength were the factors associated with decreasing the level of QOL. During the treatment, exercise enhancement on hip muscle strength and walking distance are suggested to improve their quality of life during combined therapy.
43rd Biennial Convention 2015 Theme: Serve Locally, Transform Regionally, Lead Globally.
Items submitted to a conference/event were evaluated/peer-reviewed at the time of abstract submission to the event. No other peer-review was provided prior to submission to the Henderson Repository, unless otherwise noted.
Type | Presentation |
Acquisition | Proxy-submission |
Review Type | Abstract Review Only: Reviewed by Event Host |
Format | Text-based Document |
Evidence Level | N/A |
Research Approach | N/A |
Keywords | Hepatitis C; Fatigue; Quality of Life |
Name | 43rd Biennial Convention |
Host | Sigma Theta Tau International |
Location | Las Vegas, Nevada, USA |
Date | 2015 |
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Related items
Showing items related by title, author, creator and subjects.
-
Association among cachexia syndrome, symptom distress, and quality of life in pancreatic cancer patients
Chou, Yun-Jen; Shun, Shiow-Ching (2017-06-22)Background: Cachexia syndrome is common in pancreatic cancer patients, and it will increase the mortality rate and decrease quality of life (QoL). However, there is no study with longitudinal design to explore the ... -
A comparison of fatigue among resectable colorectal and pancreatic cancer patients
Kuo, Hsuan-Ju; Shun, Shiow-Ching (2017-07-13)Purpose: Both colorectal and pancreatic cancer patients suffer from gastrointestinal associated symptoms that cause nutrition insufficiency. Under impaired nutritional status, cancer patients are prone to experience ... -
Understanding self-care coping styles in patients with chronic heart failure
Li, Chia-Chien; Shun, Shiow-Ching (2014-11-17)Session presented on Saturday, July 26, 2014: Background: Heart failure (HF) is a serious disease with poor prognosis and large numbers of people suffer from heart failure around the world. The physical and psychological ... -
Exploring posttraumatic stress disorder, depression, and quality of life in post ICU stay patients
Wang, Ching-Hui; Liu, Pei-Chen; Liu, Chia-Hui; Chen, Yu-Kuang; Ho, Li-Ing; Lin, Chien-WeiThis study report PTSD, depression and QOL at 3-5 days, 1 month, 3 months and 6 months in post ICU stay patients in Taiwan. That provide an important information that patients' physiology and psychology are not recovery ... -
Sleep quality and its associated factors in patients with chronic hepatitis C receiving antiviral therapy
Chen, Ya-Wen; Huang, Chu-Yu; Tseng, Yun Shan (2016-07-13)Session presented on Thursday, July 21, 2016: Purpose: The population with chronic hepatitis C is gradually increasing in the world. The treatment with pegylated Interferon and Ribavirin is still a standard therapy for ...